CVE-2022-48221 is an elevation of privilege vulnerability affecting Acuant AcuFill SDK versions prior to 10.22.02.03. It allows a standard user to gain SYSTEM-level code execution by exploiting a race condition and OpLock manipulation within the installer process. The vulnerability has a CVSS score of 7.5 (HIGH), indicating a network attack vector, high attack complexity, and high impact on confidentiality, integrity, and availability. Currently, there is no evidence of active exploitation, public exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion or media coverage surrounding this CVE.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
< 10.22.02.03CPE matchmatch criteria | cpe:2.3:a:gbgplc:acuant_acufill_sdk:*:*:*:*:*:*:*:* |
CVSS version used by this source: 3.1
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.2 Bluesky, 0.1 Mastodon, and 0.2 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.1 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.